Breast Cancer, Unspecified Site, Right Female Breast
Find information on right breast cancer, unspecified site (ICD-10 C50.911, SNOMED CT 71989008). This page provides resources for healthcare professionals regarding clinical documentation, medical coding, and diagnosis of breast cancer of the right breast, unspecified site. Learn about malignant neoplasm of the right breast, unspecified site and relevant medical terminology for accurate reporting and patient care.
Cancer of unspecified location in the right breast.
Lump, nipple changes, skin dimpling, swelling, pain. May be asymptomatic.
Mammography screening, primary care, breast clinic, oncology.
ICD-10 Code Families
Complete code families applicable to C50.911
When to use each related code
| Description | When to use |
|---|---|
| Right breast cancer, site unspecified | Use for malignant neoplasm of right breast when specific site is unknown. Do not use for in situ or secondary cancers. |
| Right breast cancer, nipple | Malignant neoplasm of right nipple. Do not use for Paget's disease or cancers extending to nipple from other sites. |
| Right breast cancer, central portion | Cancer overlapping central portion of right breast. Avoid if specific site (e.g., nipple) is known. |
Best-practice checklist
- ✓Right breast cancer laterality documented
- ✓Confirm site unspecified, rule out other sites
- ✓Document diagnostic basis (imaging, biopsy)
- ✓Stage if known, document grade and histology
- ✓Relevant HPI, physical exam findings noted
Common pitfalls to avoid
Coding may not accurately reflect the right breast laterality, leading to incorrect treatment or reporting.
Unspecified site coding may hinder accurate staging, treatment planning, and quality reporting. CDI can clarify.
Missing histology documentation can impact code selection and reimbursement. CDI should query for specifics.
Best-practice tips
- 01Document laterality (right breast) and confirm with imaging.
- 02Code C50.911 for ICD-10-CM (Breast, unspecified site, right).
- 03Abstract all pertinent details for accurate staging and treatment.
- 04Query physician for clarity if site-specific info is missing.
- 05Ensure medical necessity documentation for all procedures.
Step-by-step checklist
- 1
Confirm laterality: Right breast documented?
- 2
Verify histology: Is it invasive/in situ?
- 3
Check imaging reports: Location specified?
- 4
Stage documented per AJCC guidelines?
- 5
Review HPI for relevant symptoms/risk factors
Ready-to-paste narrative
Patient presents with concerns regarding her right breast health. She reports [specific symptom, e.g., a palpable lump, nipple discharge, skin changes] prompting this evaluation for right breast cancer. On physical examination, [describe findings, e.g., a palpable mass is noted in the upper outer quadrant of the right breast, measuring approximately 2 cm, firm, and non-tender; nipple retraction is present; axillary lymphadenopathy is not appreciated]. The patient's personal and family history is significant for [list relevant factors, e.g., nulliparity, early menarche, family history of breast cancer in her mother]. Given the clinical presentation, breast cancer of the right breast, unspecified site, is suspected. Differential diagnoses include benign breast conditions such as fibroadenoma, cyst, and fat necrosis. Mammography of the right breast has been ordered, followed by targeted ultrasound if indicated. Biopsy is planned to confirm the diagnosis and determine the histologic subtype. Further management, including staging and treatment planning, will be determined upon receipt of pathology results. Patient education regarding breast cancer diagnosis, treatment options including surgery, chemotherapy, radiation therapy, hormonal therapy, and targeted therapy, as well as potential side effects, was provided. The patient expressed understanding and will follow up for results and further discussion. This clinical documentation supports the diagnosis of breast cancer, unspecified site, right breast (ICD-10 C50.911) and facilitates accurate medical billing and coding for reimbursement purposes. The information provided adheres to healthcare documentation guidelines for EHR systems and reflects current clinical standards for breast cancer evaluation.
Common questions and answers
What are the key differential diagnoses to consider in a patient presenting with right breast lump suspicious for breast cancer, unspecified site, when the site of the primary tumor is unknown?+
When a patient presents with a right breast lump concerning for breast cancer, unspecified site, and the primary tumor's location remains unknown, several crucial differential diagnoses must be considered. These include benign breast conditions like fibroadenomas, cysts, and fat necrosis. Inflammatory breast conditions such as mastitis and abscesses should also be ruled out. Additionally, other malignancies, including lymphoma or metastasis from a distant primary site, warrant consideration. Accurate diagnosis relies on a combination of physical examination, imaging studies (mammography, ultrasound, and potentially MRI), and tissue biopsy for histopathological evaluation. Explore how a multidisciplinary approach involving radiology, pathology, and surgical oncology can enhance diagnostic accuracy in these cases.
How does the staging workup for right breast cancer, unspecified site differ when the primary tumor cannot be identified on imaging versus when a distinct mass is visualized?+
The staging workup for right breast cancer, unspecified site, varies depending on whether a distinct mass is visualized on imaging. If a mass is identified, the standard staging workup includes imaging of the chest, abdomen, and pelvis (CT scans or bone scans) to assess for distant metastasis. Sentinel lymph node biopsy or axillary lymph node dissection is performed to evaluate regional nodal involvement. When the primary tumor isn't visualized on imaging but a diagnosis is made based on biopsy of a suspicious area or nipple discharge, the extent of imaging may be broader to search for an occult primary. Consider implementing strategies for occult primary tumor localization, such as advanced imaging techniques or further biopsy of suspicious areas guided by mammography or ultrasound. The presence or absence of a visible mass also influences the surgical approach and subsequent treatment decisions.
What are the recommended next steps in the management of a patient with biopsy-proven right breast cancer, unspecified site if imaging studies are negative for a discernible mass or other abnormalities, focusing on the clinical approach and treatment considerations?+
In cases of biopsy-proven right breast cancer, unspecified site, where imaging studies are negative for a discernible mass or other abnormalities, management requires a nuanced approach. First, it's essential to review the biopsy results with a pathologist to confirm the diagnosis and subtype of breast cancer. Second, consider repeating or obtaining additional imaging studies, such as breast MRI or targeted ultrasound, to try and localize the tumor. If the tumor remains occult, management options may include surgical excision of the biopsy area with a margin of healthy tissue or close monitoring with regular imaging and physical examinations. Treatment decisions are individualized based on the patient's overall health, preferences, and clinicopathological findings. Learn more about the role of multidisciplinary tumor boards in guiding treatment decisions for complex breast cancer cases, especially those with occult primary tumors.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.